Timothy Nieters
Geschäftsführer bei Ambio Pharmaceuticals
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Stephen John Kiel | M | 71 |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | 4 Jahre |
| Jun Cai Bai | M | 61 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 Jahre |
| Michael William Pennington | M | 62 |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 6 Jahre |
| Peter Joe Pitts | M | 65 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 Jahre |
| Chong Sun Chung | M | 48 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 Jahre |
| Craig Marshall Lea | M | 71 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 Jahre |
| Brian Gregg | M | - |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | 1 Jahre |
| Ling Yang | F | 44 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 Jahre |
| Xiao Bo Lu | M | 51 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 Jahre |
| Shing Cheung Wong | M | 37 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | - |
| Hao Zhang | M | 42 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Chandra Wuisantono | M | 56 |
Missouri State University
| 3 Jahre |
| Robert Guest | M | 69 |
Missouri State University
| 4 Jahre |
| Greg Martin Newman | M | - |
Missouri State University
| 4 Jahre |
| Xuan Gu | M | 54 |
Missouri State University
| 3 Jahre |
| Matthew Mainer | M | 53 |
Mallinckrodt Medical, Inc. (US)
 Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Medical, Inc. is a pharmaceutical company based in St. Louis. The American company manufactures pharmaceutical products. | - |
| Christopher W. Rackers | M | 53 |
Missouri State University
| 4 Jahre |
| Rama G. Notowidigdo | M | 50 |
Missouri State University
| 4 Jahre |
| Scott Huff | M | 52 |
Missouri State University
| 5 Jahre |
| Douglas Bauche | M | 54 |
Missouri State University
| 4 Jahre |
| Bob Tucker | M | - |
Maryville University of St. Louis
| 2 Jahre |
| Douglas Pitt | M | 57 |
Missouri State University
| 4 Jahre |
| Paul Thomas Carroll | M | - |
Missouri State University
| 4 Jahre |
| Mirco Schroeter | M | 55 |
Missouri State University
| 2 Jahre |
| Geoff Pickering | M | - |
Missouri State University
| 4 Jahre |
| Williams Kevin | M | - |
Missouri State University
| 4 Jahre |
| Allen Darnell | M | - |
Missouri State University
| 4 Jahre |
| Michael E. Mathews | M | 61 |
Mallinckrodt Medical, Inc. (US)
Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Medical, Inc. is a pharmaceutical company based in St. Louis. The American company manufactures pharmaceutical products. | 2 Jahre |
| Melissa Lackey | F | - |
Maryville University of St. Louis
| 2 Jahre |
| Sean Morris | M | 52 |
Missouri State University
| 4 Jahre |
| Chris X. Moloney | M | - |
Missouri State University
| 3 Jahre |
| Rachel E. Durbin | F | - |
Missouri State University
| 4 Jahre |
| George S. Storey | M | - |
Missouri State University
| 4 Jahre |
| Linda Bannister | F | - |
Missouri State University
| 3 Jahre |
| Lanny W. Pendill | M | - |
Missouri State University
| 4 Jahre |
| John Moten | M | - |
Mallinckrodt Medical, Inc. (US)
Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Medical, Inc. is a pharmaceutical company based in St. Louis. The American company manufactures pharmaceutical products. | 3 Jahre |
| David Lester AuBuchon | M | - |
Missouri State University
| 4 Jahre |
| Troy Bethards | M | - |
Missouri State University
| 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 30 | 78,95% |
| Cayman Islands | 10 | 26,32% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Timothy Nieters
- Persönliches Netzwerk
